Cargando…
Identification of novel CD44v6-binding peptides that block CD44v6 and deliver a pro-apoptotic peptide to tumors to inhibit tumor growth and metastasis in mice
CD44v6, a splice variant of the cell surface glycoprotein CD44, acts as a co-receptor for c-Met and is upregulated in tumors with high metastatic potential. Methods: We screened a phage-displayed peptide library for peptides that selectively bind to CD44v6-overexpressing cells and exploited them to...
Autores principales: | Khan, Fatima, Gurung, Smriti, Gunassekaran, Gowri Rangaswamy, Vadevoo, Sri Murugan Poongkavithai, Chi, Lianhua, Permpoon, Uttapol, Haque, Md. Enamul, Lee, Yun-Ki, Lee, Soo-Woong, Kim, Soyoun, Lee, Byungheon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738880/ https://www.ncbi.nlm.nih.gov/pubmed/33391537 http://dx.doi.org/10.7150/thno.50564 |
Ejemplares similares
-
Peptides as multifunctional players in cancer therapy
por: Vadevoo, Sri Murugan Poongkavithai, et al.
Publicado: (2023) -
Epigenetic therapy reprograms M2-type tumor-associated macrophages into an M1-like phenotype by upregulating miR-7083-5p
por: Vadevoo, Sri Murugan Poongkavithai, et al.
Publicado: (2022) -
A Phage Display-Identified Peptide Selectively Binds to Kidney Injury Molecule-1 (KIM-1) and Detects KIM-1–Overexpressing Tumors In Vivo
por: Haque, Md. Enamul, et al.
Publicado: (2019) -
Interleukin-4 Receptor Targeting Peptide Decorated Extracellular Vesicles as a Platform for In Vivo Drug Delivery to Thyroid Cancer
por: Gangadaran, Prakash, et al.
Publicado: (2022) -
Designed ferritin nanocages displaying trimeric TRAIL and tumor-targeting peptides confer superior anti-tumor efficacy
por: Yoo, Jae Do, et al.
Publicado: (2020)